查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1836330

2032 年女性荷尔蒙健康与保健市场预测：按产品类型、类型、服务提供、分销管道、最终用户和地区进行的全球分析

Women's Hormonal Health & Wellness Market Forecasts to 2032 - Global Analysis By Product Type (Supplements, Functional Foods and Hormonal Therapy), Type, Service Delivery, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球女性荷尔蒙健康和保健市场预计在 2025 年达到 49 亿美元，到 2032 年将达到 82 亿美元，预测期内的复合年增长率为 7.7%。

女性荷尔蒙健康与保健专注于管理从月经、不孕到更年期等各个生命阶段的荷尔蒙变化。该市场涵盖诊断产品、补充剂、数位健康应用程式和远端医疗平台，旨在解决多囊性卵巢症候群 (PCOS)、甲状腺失衡和情绪障碍等问题。市场强调个人化护理、教育和赋权。随着人们对性别特定解决方案的认识和需求日​​益增长，该领域正在重塑医疗保健，优先为女性的生理、情感和生殖健康提供全面的、科学支持的支持。

根据国际妇科内分泌学会 (ISGE) 的说法，数位健康创新正在透过个人化荷尔蒙追踪、预测週期分析和整体内分泌支持解决方案改变女性的荷尔蒙健康。

对个人化健康解决方案的需求

推动这一市场发展的是，消费者越来越倾向于寻求满足个人需求的客製化荷尔蒙健康产品和服务。人们对多囊性卵巢症候群 (PCOS)、更年期和甲状腺失衡等疾病的认识不断提高，催生了对针对性解决方案的需求，而不仅仅是普通补充剂。个人化营养、基于 DNA 的健康评估以及以荷尔蒙为中心的健康计划正日益普及。在生物技术进步和人工智慧驱动的健康洞察的推动下，这些客製化方案正变得越来越普及。因此，企业正在利用消费者对个人化健康策略的需求。

生殖健康的社会耻辱

由于围绕生殖健康讨论的社会污名化和文化敏感性，市场面临许多障碍。在某些地区，女性健康问题，尤其是荷尔蒙失衡和不孕症问题，很少被公开讨论，导致诊断不足和治疗延迟。这种污名化限制了宣传宣传活动，并限制了人们的就医行为。此外，围绕月经和更年期的禁忌阻碍了消费者对相关产品的接受度。缺乏对话也影响了女性荷尔蒙健康技术创新的资金筹措。这些因素共同限制了市场拓展机会。

用于荷尔蒙追踪的数位平台

不断扩展的数位健康平台为女性荷尔蒙健康市场带来了巨大的机会。监测荷尔蒙波动、月经週期和生育模式的行动应用程式和穿戴式技术日益普及。在数位化的推动下，消费者现在可以获得即时数据洞察，从而进行主动的健康管理。这些平台还支持与内分泌科医生和妇科医生进行远距咨询，从而弥合医疗保健服务可近性的差距。人工智慧主导的分析技术的整合进一步增强了预测能力。这些技术创新预计将为市场参与企业提供强劲的成长途径。

补充剂声明的监管障碍

关于补充剂安全和标籤的严格监管仍然是市场成长的主要威胁。美国和欧盟等地区的监管机构对荷尔蒙支持补充剂相关健康声明的临床检验提出了严格的要求。这通常会延迟产品发布并增加合规成本。假讯息的风险进一步加剧了消费者的疑虑。此外，不同地区法规结构的差异使企业的全球扩张策略更加复杂。这些挑战可能使成熟企业和新兴企业都难以保持竞争力。

COVID-19的影响：

疫情对女性的荷尔蒙健康和身心健康产生了双重影响。一方面，压力水平的增加和生活方式的改变加剧了荷尔蒙失衡，导致对补充剂和压力管理解决方案的需求增加。另一方面，供应链中断和医疗服务取得管道的受限对产品供应产生了负面影响。远端保健的普及加速，推动了数位咨询和荷尔蒙追踪应用程式的使用。由于消费者在危机期间更加积极主动地进行自我护理，该领域出现了长期的行为转变，这增强了疫情后市场需求的韧性。

预测期内，补充剂市场预计将成为最大的市场

预计膳食补充剂领域将在预测期内占据最大的市场份额，这得益于维生素、草药萃取物以及针对荷尔蒙平衡的膳食补充剂的普及。这一趋势源自于越来越多的消费者使用膳食补充剂来支持更年期、改善月经健康和增强生育能力。此外，消费者对天然和植物来源的偏好也扩大了这类产品在各个年龄层的吸引力。多亏线上零售的广泛普及，补充剂的取得更加便捷，选择也更加多样化。该领域的主导地位反映了其作为主要干预手段的作用。

预计预测期内，月经健康领域将以最高复合年增长率成长

由于人们对月经卫生和多囊性卵巢症候群 (PCOS) 等荷尔蒙失调的认识不断提高，预计月经月经领域将在预测期内实现最高成长率。月经追踪应用程式、穿戴式装置和荷尔蒙平衡疗法的普及将进一步推动这一成长。月经保健补充剂和数位咨询服务的创新正在增强其普及率。千禧世代和 Z 世代女性对健康话题的讨论越来越开放，推动了消费者的转变。强劲的需求证实了月经健康是一个高成长的子市场。

占比最大的地区：

预计亚太地区将在预测期内占据最大的市场份额。这得归功于人口结构的成长、健康意识的增强以及女性对健康产品的日益普及。中阶收入水准的提高以及政府支持女性健康的倡议，也为成长注入了新的动力。此外，传统草药与现代膳食补充剂的结合正逐渐受到消费者的青睐。中国、印度和日本等国家对补充剂和数位健康平台的需求强劲。这些因素共同作用，使亚太地区成为市场的主要贡献者。

复合年增长率最高的地区：

预计北美地区在预测期内将呈现最高的复合年增长率，这得益于强劲的技术应用和消费者对个人化健康的追求。先进补充剂、荷尔蒙追踪穿戴式装置和远端健康管理平台的广泛普及将推动成长。此外，女性生殖权利的倡议日益高涨，将减少对荷尔蒙健康的污名化，并鼓励大众就荷尔蒙健康展开公开讨论。总部位于美国的主要市场参与者将加速其创新管道建设并扩大产品系列。随着数位健康基础设施投资的不断增加，北美市场有望实现强劲扩张。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球女性荷尔蒙健康与保健市场（依产品类型）

  • 补充
  • 机能性食品
  • 荷尔蒙疗法

6. 全球女性荷尔蒙健康与保健市场（按类型）

  • 月经健康
  • 生育能力
  • 怀孕
  • 闭经
  • 荷尔蒙平衡

7. 全球女性荷尔蒙健康与保健市场（按服务提供）

  • 数位健康
  • 面对面咨询
  • 混合模式

8. 全球女性荷尔蒙健康与保健市场（按分销管道）

  • 药局
  • 网路零售
  • 诊所
  • 专卖店
  • 直接面向消费者

9. 全球女性荷尔蒙健康与保健市场（按最终用户）

  • 青年
  • 育龄妇女
  • 停经后妇女

10. 全球女性荷尔蒙健康与保健市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • AbbVie
  • Bayer
  • Organon & Co.
  • Pfizer
  • Theramex
  • Agile Therapeutics
  • Amgen
  • Apothecus Pharmaceutical
  • Blairex Laboratories
  • Ferring
  • Roche
  • Hologic
  • Johnson & Johnson
  • Eli Lilly
  • Siemens
  • Medtronic
  • Philips
Product Code: SMRC31454

According to Stratistics MRC, the Global Women's Hormonal Health & Wellness Market is accounted for $4.9 billion in 2025 and is expected to reach $8.2 billion by 2032 growing at a CAGR of 7.7% during the forecast period. Women's hormonal health and wellness focuses on managing hormonal changes across life stages-from menstruation and fertility to menopause. This market includes diagnostics, supplements, digital health apps, and telemedicine platforms addressing issues like PCOS, thyroid imbalance, and mood disorders. It emphasizes personalized care, education, and empowerment. With rising awareness and demand for gender-specific solutions, this sector is reshaping healthcare by prioritizing holistic, science-backed support for women's physical, emotional, and reproductive well-being.

According to the International Society for Gynecological Endocrinology (ISGE), digital health innovation is transforming women's hormonal wellness through personalized hormone tracking, predictive cycle analytics, and holistic endocrine support solutions.

Market Dynamics:

Driver:

Demand for personalized wellness solutions

The market is spurred by a rising consumer inclination toward tailored hormonal health products and services that address individual needs. Growing awareness of conditions such as PCOS, menopause, and thyroid imbalance has created demand for targeted solutions beyond general supplements. Personalized nutrition, DNA-based health assessments, and hormone-focused wellness programs are gaining traction. Fueled by advancements in biotechnology and AI-driven health insights, these customized approaches are becoming more accessible. Consequently, companies are capitalizing on consumer demand for individualized wellness strategies.

Restraint:

Social stigma around reproductive health

The market encounters barriers due to prevailing social stigma and cultural sensitivity surrounding reproductive health discussions. In several regions, women's health issues, particularly hormonal imbalances and fertility concerns, are rarely addressed openly, leading to under-diagnosis and delayed treatment. This stigma limits awareness campaigns and restricts healthcare-seeking behavior. Moreover, taboos around menstruation and menopause hinder consumer acceptance of related products. The lack of dialogue also impacts funding for innovation in women's hormonal wellness. These factors collectively constrain market expansion opportunities.

Opportunity:

Digital platforms for hormone tracking

Expanding digital health platforms present a significant opportunity for the women's hormonal wellness market. Mobile apps and wearable technologies that monitor hormonal fluctuations, menstrual cycles, and fertility patterns are increasingly popular. Driven by digitalization, consumers now have access to real-time data insights for proactive health management. These platforms also enable teleconsultation with endocrinologists and gynecologists, bridging gaps in healthcare accessibility. The integration of AI-driven analytics further strengthens predictive capabilities. Such innovations are expected to create strong growth avenues for market participants.

Threat:

Regulatory hurdles for supplement claims

Stringent regulations on supplement safety and labeling remain a major threat to market growth. Authorities in regions such as the U.S. and EU impose strict requirements for clinical validation of health claims associated with hormone-support supplements. This often delays product launches and increases compliance costs. Misinformation risks further trigger consumer skepticism. Additionally, differences in regulatory frameworks across regions complicate global expansion strategies for companies. These hurdles may challenge both established players and startups in sustaining competitiveness.

Covid-19 Impact:

The pandemic had a dual impact on women's hormonal health and wellness. On one hand, heightened stress levels and lifestyle disruptions aggravated hormonal imbalances, leading to increased demand for supplements and stress management solutions. On the other hand, supply chain disruptions and restricted access to healthcare services negatively affected product availability. Telehealth adoption accelerated, driving digital consultations and hormone-tracking app usage. As consumers became more proactive about self-care during the crisis, the sector witnessed long-term behavioral shifts. This fostered resilience in market demand post-pandemic.

The supplements segment is expected to be the largest during the forecast period

The supplements segment is expected to account for the largest market share during the forecast period, owing to widespread adoption of vitamins, herbal extracts, and nutraceuticals targeting hormonal balance. Increasing consumer reliance on dietary supplements for menopause support, menstrual wellness, and fertility enhancement drives this trend. Additionally, the preference for natural and plant-based formulations has broadened product appeal across age groups. Backed by online retail penetration, supplements offer convenient access and diverse choices. This segment's dominance reflects its role as the primary intervention method.

The menstrual health segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the menstrual health segment is predicted to witness the highest growth rate by rising awareness of menstrual hygiene and hormonal disorders such as PCOS. Increasing adoption of period-tracking apps, wearable devices, and hormone-balancing therapies further propels this growth. Innovations in menstrual wellness supplements and digital consultation services strengthen adoption. Millennials and Gen Z women, with heightened openness toward health discussions, are driving consumer shifts. This strong demand underscores menstrual health as a high-growth submarket.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by driven by growing population demographics, increased health awareness, and rising adoption of wellness products among women. Expanding middle-class income levels and government initiatives supporting women's health amplify growth momentum. Furthermore, traditional herbal medicine practices integrated with modern nutraceuticals gain strong consumer acceptance. Countries such as China, India, and Japan exhibit robust demand across supplements and digital health platforms. Collectively, these factors position Asia Pacific as a leading market contributor.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR attributed to strong technological adoption and consumer willingness to embrace personalized wellness. Widespread availability of advanced supplements, hormone-tracking wearables, and telehealth platforms accelerates growth. Additionally, increasing advocacy for women's reproductive rights reduces stigma and encourages open discussions around hormonal health. Major market players headquartered in the U.S. fuel innovation pipelines and expand product portfolios. With growing investments in digital health infrastructure, North America is set for dynamic expansion.

Key players in the market

Some of the key players in Women's Hormonal Health & Wellness Market include AbbVie, Bayer, Organon & Co., Pfizer, Theramex, Agile Therapeutics, Amgen, Apothecus Pharmaceutical, Blairex Laboratories, Ferring, Roche, Hologic, Johnson & Johnson, Eli Lilly, Siemens, Medtronic and Philips.

Key Developments:

In August 2025, Organon & Co. intensified its access strategy in India by partnering with India's national family planning program to pilot rollout of Implanon NXT, a subdermal single-rod contraceptive implant.

In February 2025, Organon & Co. reported Phase 2 trial results for OG-6219 (a HSD17B1 inhibitor) in endometriosis-related pain. The trial did not meet its primary efficacy endpoint, and Organon subsequently discontinued development of the OG-6219 program.

Product Types Covered:

  • Supplements
  • Functional Foods
  • Hormonal Therapy

Types Covered:

  • Menstrual Health
  • Fertility
  • Pregnancy
  • Menopause
  • Hormonal Balance

Service Deliveries Covered:

  • Digital Health
  • In-Person Clinics
  • Hybrid Models

Distribution Channels Covered:

  • Pharmacies
  • Online Retail
  • Clinics
  • Specialty Stores
  • Direct-To-Consumer

End Users Covered:

  • Adolescents
  • Reproductive Age Women
  • Post-Menopausal Women

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Women's Hormonal Health & Wellness Market, By Product Type

  • 5.1 Introduction
  • 5.2 Supplements
  • 5.3 Functional Foods
  • 5.4 Hormonal Therapy

6 Global Women's Hormonal Health & Wellness Market, By Type

  • 6.1 Introduction
  • 6.2 Menstrual Health
  • 6.3 Fertility
  • 6.4 Pregnancy
  • 6.5 Menopause
  • 6.6 Hormonal Balance

7 Global Women's Hormonal Health & Wellness Market, By Service Delivery

  • 7.1 Introduction
  • 7.2 Digital Health
  • 7.3 In-Person Clinics
  • 7.4 Hybrid Models

8 Global Women's Hormonal Health & Wellness Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Pharmacies
  • 8.3 Online Retail
  • 8.4 Clinics
  • 8.5 Specialty Stores
  • 8.6 Direct-To-Consumer

9 Global Women's Hormonal Health & Wellness Market, By End User

  • 9.1 Introduction
  • 9.2 Adolescents
  • 9.3 Reproductive Age Women
  • 9.4 Post-Menopausal Women

10 Global Women's Hormonal Health & Wellness Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 AbbVie
  • 12.2 Bayer
  • 12.3 Organon & Co.
  • 12.4 Pfizer
  • 12.5 Theramex
  • 12.6 Agile Therapeutics
  • 12.7 Amgen
  • 12.8 Apothecus Pharmaceutical
  • 12.9 Blairex Laboratories
  • 12.10 Ferring
  • 12.11 Roche
  • 12.12 Hologic
  • 12.13 Johnson & Johnson
  • 12.14 Eli Lilly
  • 12.15 Siemens
  • 12.16 Medtronic
  • 12.17 Philips

List of Tables

  • Table 1 Global Women's Hormonal Health & Wellness Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Women's Hormonal Health & Wellness Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Women's Hormonal Health & Wellness Market Outlook, By Supplements (2024-2032) ($MN)
  • Table 4 Global Women's Hormonal Health & Wellness Market Outlook, By Functional Foods (2024-2032) ($MN)
  • Table 5 Global Women's Hormonal Health & Wellness Market Outlook, By Hormonal Therapy (2024-2032) ($MN)
  • Table 6 Global Women's Hormonal Health & Wellness Market Outlook, By Type (2024-2032) ($MN)
  • Table 7 Global Women's Hormonal Health & Wellness Market Outlook, By Menstrual Health (2024-2032) ($MN)
  • Table 8 Global Women's Hormonal Health & Wellness Market Outlook, By Fertility (2024-2032) ($MN)
  • Table 9 Global Women's Hormonal Health & Wellness Market Outlook, By Pregnancy (2024-2032) ($MN)
  • Table 10 Global Women's Hormonal Health & Wellness Market Outlook, By Menopause (2024-2032) ($MN)
  • Table 11 Global Women's Hormonal Health & Wellness Market Outlook, By Hormonal Balance (2024-2032) ($MN)
  • Table 12 Global Women's Hormonal Health & Wellness Market Outlook, By Service Delivery (2024-2032) ($MN)
  • Table 13 Global Women's Hormonal Health & Wellness Market Outlook, By Digital Health (2024-2032) ($MN)
  • Table 14 Global Women's Hormonal Health & Wellness Market Outlook, By In-Person Clinics (2024-2032) ($MN)
  • Table 15 Global Women's Hormonal Health & Wellness Market Outlook, By Hybrid Models (2024-2032) ($MN)
  • Table 16 Global Women's Hormonal Health & Wellness Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 17 Global Women's Hormonal Health & Wellness Market Outlook, By Pharmacies (2024-2032) ($MN)
  • Table 18 Global Women's Hormonal Health & Wellness Market Outlook, By Online Retail (2024-2032) ($MN)
  • Table 19 Global Women's Hormonal Health & Wellness Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 20 Global Women's Hormonal Health & Wellness Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 21 Global Women's Hormonal Health & Wellness Market Outlook, By Direct-To-Consumer (2024-2032) ($MN)
  • Table 22 Global Women's Hormonal Health & Wellness Market Outlook, By End User (2024-2032) ($MN)
  • Table 23 Global Women's Hormonal Health & Wellness Market Outlook, By Adolescents (2024-2032) ($MN)
  • Table 24 Global Women's Hormonal Health & Wellness Market Outlook, By Reproductive Age Women (2024-2032) ($MN)
  • Table 25 Global Women's Hormonal Health & Wellness Market Outlook, By Post-Menopausal Women (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.